The Septoplasty Healthcare Monitor: An Outcome Assessment Infrastructure to Enhance the Quality and Transparency of Care

IF 1.9 4区医学 Q2 OTORHINOLARYNGOLOGY

Clinical Otolaryngology Pub Date : 2026-06-03 Epub Date: 2026-03-13 DOI:10.1111/coa.70099

Victor S. van Dam, Diako Berzenji, Floris V. W. J. van Zijl, Martijn A. H. Oude Voshaar, Bernd Kremer, Frank R. Datema

{"title":"The Septoplasty Healthcare Monitor: An Outcome Assessment Infrastructure to Enhance the Quality and Transparency of Care","authors":"Victor S. van Dam, Diako Berzenji, Floris V. W. J. van Zijl, Martijn A. H. Oude Voshaar, Bernd Kremer, Frank R. Datema","doi":"10.1111/coa.70099","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective and Design</h3>\n \n <p>The growing demand for transparency about the efficacy of healthcare has accelerated the use of Patient-Reported Outcome Measures (PROMs), but their integration into daily practice is challenging. This observational study describes how the Septoplasty Healthcare Monitor (SHM) addresses these challenges and highlights the benefits of standardised outcome assessments and visualisation for various stakeholders, including physicians and patients.</p>\n </section>\n \n <section>\n \n <h3> Main Outcome Measures</h3>\n \n <p>Since 2014, all eligible septoplasty patients have been included in the SHM. Patients are automatically offered the Nasal Obstruction Symptom Evaluation (NOSE) scale and bilateral Visual Analogue Scales (VAS) to assess nasal obstruction before initial consultation and during postoperative visits. Data are entered into a preformatted database and automatically analysed. Real-time results are visually presented on a user-friendly dashboard.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A total of 173 patients participated. First, the dashboard provides insights into outcomes on a cohort level. The mean NOSE scores significantly decreased from 68.8 ± 19.0 at baseline to 19.8 ± 22.3 at 12 months (Cohen's <i>d</i> = −1.96). VAS scores improved from 4.6 ± 3.0 (left) and 4.7 ± 2.9 (right) preoperatively to 7.5 ± 2.1 (left) and 7.6 ± 1.7 (right) at 12 months (<i>p</i> < 0.001; <i>d</i> = 0.85; <i>d</i> = 1.05). Second, quality of care is monitored through annual performance metrics and can be improved by critically appraising auto-identified underperforming patients. Third, visualisation of individual PROM symptom-severity scores in relation to peers assists in patient-counselling and shared decision-making.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The integration of standardised outcome assessments into daily practice is highly valuable but challenging. The SHM addresses these challenges and offers opportunities to enhance septoplasty care standards.</p>\n </section>\n </div>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":"51 4","pages":"538-547"},"PeriodicalIF":1.9000,"publicationDate":"2026-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/coa.70099","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Otolaryngology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/coa.70099","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/13 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective and Design

The growing demand for transparency about the efficacy of healthcare has accelerated the use of Patient-Reported Outcome Measures (PROMs), but their integration into daily practice is challenging. This observational study describes how the Septoplasty Healthcare Monitor (SHM) addresses these challenges and highlights the benefits of standardised outcome assessments and visualisation for various stakeholders, including physicians and patients.

Main Outcome Measures

Since 2014, all eligible septoplasty patients have been included in the SHM. Patients are automatically offered the Nasal Obstruction Symptom Evaluation (NOSE) scale and bilateral Visual Analogue Scales (VAS) to assess nasal obstruction before initial consultation and during postoperative visits. Data are entered into a preformatted database and automatically analysed. Real-time results are visually presented on a user-friendly dashboard.

Results

A total of 173 patients participated. First, the dashboard provides insights into outcomes on a cohort level. The mean NOSE scores significantly decreased from 68.8 ± 19.0 at baseline to 19.8 ± 22.3 at 12 months (Cohen's d = −1.96). VAS scores improved from 4.6 ± 3.0 (left) and 4.7 ± 2.9 (right) preoperatively to 7.5 ± 2.1 (left) and 7.6 ± 1.7 (right) at 12 months (p < 0.001; d = 0.85; d = 1.05). Second, quality of care is monitored through annual performance metrics and can be improved by critically appraising auto-identified underperforming patients. Third, visualisation of individual PROM symptom-severity scores in relation to peers assists in patient-counselling and shared decision-making.

Conclusion

The integration of standardised outcome assessments into daily practice is highly valuable but challenging. The SHM addresses these challenges and offers opportunities to enhance septoplasty care standards.

Abstract Image

查看原文本刊更多论文

中隔成形术医疗监视器：提高护理质量和透明度的结果评估基础设施。

目标和设计：对医疗保健效果透明度的需求日益增长，这加速了患者报告结果测量（PROMs）的使用，但将其整合到日常实践中是具有挑战性的。本观察性研究描述了鼻中隔成形术保健监视器（SHM）如何应对这些挑战，并强调了标准化结果评估和可视化对各种利益相关者（包括医生和患者）的好处。主要观察指标：自2014年以来，所有符合条件的中隔成形术患者均纳入SHM。在初次会诊前和术后就诊期间，自动为患者提供鼻塞症状评估（NOSE）量表和双侧视觉模拟量表（VAS）来评估鼻塞。数据被输入一个预先格式化的数据库并自动分析。实时结果直观地呈现在用户友好的仪表板上。结果：共173例患者参与。首先，仪表板提供了对队列水平结果的洞察。平均鼻子评分从基线时的68.8±19.0显著下降到12个月时的19.8±22.3 （Cohen’s d = -1.96）。VAS评分从术前的4.6±3.0分（左）和4.7±2.9分（右）提高到12个月时的7.5±2.1分（左）和7.6±1.7分（右）(p)结论：将标准化的结果评估纳入日常实践是非常有价值的，但具有挑战性。SHM解决了这些挑战，并提供了提高鼻中隔成形术护理标准的机会。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Otolaryngology 医学-耳鼻喉科学

CiteScore

4.00

自引率

4.80%

发文量

106

审稿时长

>12 weeks

期刊介绍： Clinical Otolaryngology is a bimonthly journal devoted to clinically-oriented research papers of the highest scientific standards dealing with: current otorhinolaryngological practice audiology, otology, balance, rhinology, larynx, voice and paediatric ORL head and neck oncology head and neck plastic and reconstructive surgery continuing medical education and ORL training The emphasis is on high quality new work in the clinical field and on fresh, original research. Each issue begins with an editorial expressing the personal opinions of an individual with a particular knowledge of a chosen subject. The main body of each issue is then devoted to original papers carrying important results for those working in the field. In addition, topical review articles are published discussing a particular subject in depth, including not only the opinions of the author but also any controversies surrounding the subject. • Negative/null results In order for research to advance, negative results, which often make a valuable contribution to the field, should be published. However, articles containing negative or null results are frequently not considered for publication or rejected by journals. We welcome papers of this kind, where appropriate and valid power calculations are included that give confidence that a negative result can be relied upon.